MX9802816A - Derivados de pirimidina. - Google Patents

Derivados de pirimidina.

Info

Publication number
MX9802816A
MX9802816A MX9802816A MX9802816A MX9802816A MX 9802816 A MX9802816 A MX 9802816A MX 9802816 A MX9802816 A MX 9802816A MX 9802816 A MX9802816 A MX 9802816A MX 9802816 A MX9802816 A MX 9802816A
Authority
MX
Mexico
Prior art keywords
alkyl
signifies
signify
alkoxy
compounds
Prior art date
Application number
MX9802816A
Other languages
English (en)
Other versions
MXPA98002816A (es
Inventor
Thierry Godel
Claus Riemer
Albrecht Edenhofer
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX9802816A publication Critical patent/MX9802816A/es
Publication of MXPA98002816A publication Critical patent/MXPA98002816A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La invencion se refiere a compuestos de la formula general (1), caracterizado porque R1 Y R2 cada uno significan individualmente amino o alquilo inferiores, A significa A1, A2, A3, A4, A5, A6, A7-; B significa hidrogeno en A4, A5 y A6; (i) en A1 - A6; alquilo inferior en A4 -A6; y alquilo inferior, estirilo, feniletimilo o benzoiloxi-alquilo inferior en A1 y A2; n significa 0, 2 m,p significa 0,1 y R3, R4, R5 y R6 cada uno significa independientemente, hidrogeno, halogeno, alquilo inferior, trifluorometilo, alcoxi inferior o nitro, y las sales de adicion del ácido farmacéuticamente aceptables del mismo. Estos compuestos se pueden usar en el control o prevencion de enfermedades las cuales son causadas por desordenes del sistema de la dopamina. Enfermedades sicoticas tales como por ejemplo, esquizofrenia correspondiente a estos.
MXPA/A/1998/002816A 1995-10-10 1998-04-08 Derivados de pirimidina MXPA98002816A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH2855/95 1995-10-10
CH285595 1995-10-10
CH1625/96 1996-06-28
CH162596 1996-06-28

Publications (2)

Publication Number Publication Date
MX9802816A true MX9802816A (es) 1998-09-30
MXPA98002816A MXPA98002816A (es) 1998-11-16

Family

ID=

Also Published As

Publication number Publication date
US5688798A (en) 1997-11-18
PT873317E (pt) 2001-09-28
TR199800636T1 (xx) 1998-06-22
BR9611037A (pt) 1999-07-06
DE69612512D1 (de) 2001-05-17
ES2157463T3 (es) 2001-08-16
JP3013940B2 (ja) 2000-02-28
ATE200486T1 (de) 2001-04-15
CA2233502A1 (en) 1997-04-17
WO1997013759A1 (en) 1997-04-17
DE69612512T2 (de) 2002-03-28
DK0873317T3 (da) 2001-08-06
GR3036177T3 (en) 2001-10-31
EP0873317B1 (en) 2001-04-11
CN1199397A (zh) 1998-11-18
JPH11500745A (ja) 1999-01-19
EP0873317A1 (en) 1998-10-28

Similar Documents

Publication Publication Date Title
NO942953L (no) 11-benzaldoksimestradienderivater, fremgangsmåte for deres fremstilling smat legemddel inneholdende slike
NZ514487A (en) Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands
HUP0101999A2 (hu) 4-Hidroxi-kinolin-3-karboxamid- és -hidrazid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint e vegyületek alkalmazása
CO5031285A1 (es) Triarilimidazoles
DE69604714D1 (de) Stilbenderivate und diese enthaltende pharmazeutische Zusammensetzungen
GR3036177T3 (en) Pyrimidin derivatives
MX9708595A (es) Derivados de bencil piperidina como agentes farmaceuticos.
NO942952D0 (no) 11-benzaldoksin-17 ater, fremgangsmåte for deres fremstilling samt legemiddel inneholdende slike
BG104069A (en) 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1h-indole derivatives interacting with the dopamine d4 receptor
CA2234319A1 (en) Fluoro-substituted adamantane derivatives
MY117092A (en) Chemotherapeutic pyrrolocarbazole derivatives
CA2254117A1 (en) 2,4-diaminopyrimidine derivatives
DE69713067D1 (de) Aminotetralinderivate, deren zusammensetzungen sowie deren verwendung
CA2136008A1 (en) Substituted (arylalkylaminobenzyl)amino-propionamide derivatives and process for their preparation
MXPA99009882A (es) Derivados de amidina como inhibidores de la oxidonitrico sintasa.
KR970002634B1 (en) Aminobenzoic acid derivatives
DE69627519D1 (de) Sesquiterpen-derivate mit antiviraler aktivität
ATE58135T1 (de) 1,3-oxathianderivate.
EP0686641A4 (en) 2'-DESOXY-5-FLUOROURIDINE DERIVATIVE, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PROCESS FOR PRODUCING SAME AND ANTI-TUMOR MEDICINAL PRODUCT
CA2105665A1 (en) Diphenylthiazole Derivative
MX9709393A (es) Uso de derivados de fenoxipiridina para el tratamiento de enfermedades causadas por transtornos del sistema dopamina.
DK0573360T3 (da) Pyrrolothienopyrazinforbindelser som 5-HT3-receptorantagonister
AR004009A1 (es) Compuestos de pirimidina, procedimiento de fabricacion de los mismos, medicamentos que los contienen y utilizacion de dichos compuestos

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees